A multi‐centre retrospective study of long‐term outcomes of spinal re‐irradiation with SABR
Journal of Medical Imaging and Radiation Oncology · 2024
DOI: 10.1111/1754-9485.13723 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Medical Imaging and Radiation Oncology, 2024. Verfasst von Edward Chmiel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Spinal Neoplasms, Re-Irradiation, Radiosurgery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Introduction
Stereotactic ablative body radiotherapy (SABR) is a highly conformal technique utilising a high dose per fraction commonly employed in the re‐treatment of spinal metastases. This study sought to determine the safety and efficacy of re‐irradiation with SABR to previously treated spinal metastases.
Methods
This was a retrospective analysis of patients at three Australian centres who have undergone spinal SABR after previous spinal radiotherapy to the same or immediately adjacent vertebral level. Efficacy was determined in terms of rates of local control, while safety was characterised by rates of serious complications.
Results
Thirty‐three spinal segments were evaluated from 32 patients. Median follow‐up for all patients was 2.6 years, and median overall survival was 4.3 years. Eleven of 33 (33.3%) treated spinal segments had local progression, with a local control rate at 12 months of 71.4% (95% C.I. 55.2%–92.4%). Four patients (16.7%) went on to develop cauda equina or spinal cord compression. Thirteen out of 32 patients (40.6%) experienced acute toxicity, of which 12 were grade 2 or less. Five out of 30 spinal (16.7%) segments with follow‐up imaging had a radiation‐induced vertebral compression fracture. There was one case of radiation myelitis which occurred in a patient who had mediastinal radiotherapy with a treatment field which overlapped their prior spinal radiation.
Conclusion
The patients in this study experienced long median survival, durable tumour control and high rates of freedom from long‐term sequelae of treatment. These results support the use of SABR in patients who progress in the spine despite previous radiotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Alfred Health Radiation Oncology, Melbourne, Victoria, Australia.
- Central Clinical School, Monash University, Melbourne, Victoria, Australia.
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
- Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Medical Imaging and Radiation Sciences, Monash University, Melbourne, Victoria, Australia.
ORCID-Profile: Edward Chmiel, Nicholas Hardcastle, Farshad Foroudi
Zitieren
APA
Chmiel, E., Senthi, S., Siva, S., Hardcastle, N., Panettieri, V., Russell, C., Tacey, M., Anderson, N., & Foroudi, F. (2024). A multi‐centre retrospective study of long‐term outcomes of spinal re‐irradiation with SABR. Journal of Medical Imaging and Radiation Oncology. https://doi.org/10.1111/1754-9485.13723
Vancouver
Chmiel E, Senthi S, Siva S, Hardcastle N, Panettieri V, Russell C, et al. A multi‐centre retrospective study of long‐term outcomes of spinal re‐irradiation with SABR. Journal of Medical Imaging and Radiation Oncology. 2024. doi:10.1111/1754-9485.13723
BibTeX
@article{Chmiel2024,
author = {Chmiel, Edward and Senthi, Sashendra and Siva, Shankar and Hardcastle, Nicholas and Panettieri, Vanessa and Russell, Catherine and Tacey, Mark and Anderson, Nigel and Foroudi, Farshad},
title = {A multi‐centre retrospective study of long‐term outcomes of spinal re‐irradiation with SABR},
journal = {Journal of Medical Imaging and Radiation Oncology},
year = {2024},
doi = {10.1111/1754-9485.13723}
}
EUVIMED